Switch to:
More From Other Websites
Jazz Pharma (JAZZ) Stock Receives 'Outperform' Rating at BMO Capital Jun 29 2016
Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator... Jun 26 2016
Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator... Jun 26 2016
Five companies that could buy Ariad this year for as much as $2.9B Jun 23 2016
Jazz Pharmaceuticals PLC Conference Call to Discuss On JZP-110 Investor Update scheduled for 4:30 pm... Jun 20 2016
Jazz Pharmaceuticals Plc – Value Analysis (NASDAQ:JAZZ) : June 20, 2016 Jun 20 2016
Jazz Pharmaceuticals Offers HAL Study Data on JZP-110 Jun 15 2016
Jazz Pharmaceuticals Announces Conference Call and Webcast for JZP-110 Investor Update Jun 14 2016
Jazz Pharmaceuticals Announces Conference Call and Webcast for JZP-110 Investor Update Jun 14 2016
Jazz Pharmaceuticals Presents New Data from a Human Abuse Liability (HAL) Study for JZP-110, an... Jun 14 2016
Jazz Pharmaceuticals Presents New Data from a Human Abuse Liability (HAL) Study for JZP-110, an... Jun 14 2016
Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : JAZZ-US : June 14,... Jun 14 2016
5 Appealing Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016
Jazz Pharma Started At Buy; Visa And Wal-Mart Upgraded Jun 06 2016
Specialty Pharma: After the M&A Fueled Super Cycle Jun 06 2016
Coverage initiated on Jazz Pharma by Goldman Jun 06 2016
Celator Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of CPXX Shareholders Jun 03 2016
Sarepta Therapeutics: Bears are 'Fundamentally Wrong.' Here's Why. Jun 03 2016
The market is looking for a Celator spoiler bid Jun 03 2016
Yes, Biotech Unicorns Are Still Real Jun 01 2016
Jazz Pharma to buy Celator in $1.5 billion deal May 31 2016
Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To... May 31 2016
Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ May 30 2016
Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences May 18 2016
Jazz misses Street 1Q forecasts May 10 2016
Jazz Pharmaceuticals Announces First Quarter 2016 Financial Results May 10 2016
Jazz Pharmaceuticals to Report 2016 First Quarter Financial Results on May 10, 2016 Apr 26 2016
Jazz Pharmaceuticals Announces Webcast for Defitelio® (defibrotide sodium) Investor Update Mar 30 2016
Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide sodium) for the Treatment of... Mar 30 2016
Jazz beats 4Q profit forecasts Feb 23 2016
Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 11 Jan 04 2016
Jazz misses Street 3Q forecasts Nov 09 2015
Jazz Pharmaceuticals Announces Third Quarter 2015 Financial Results Nov 09 2015
Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences Nov 04 2015
Jazz Pharmaceuticals to Report 2015 Third Quarter Financial Results on November 9, 2015 Oct 26 2015
Jazz meets 2Q profit forecasts Aug 05 2015
Jazz Pharmaceuticals Announces Second Quarter 2015 Financial Results Aug 05 2015
Jazz Pharmaceuticals to Report 2015 Second Quarter Financial Results on August 5, 2015 Jul 22 2015
Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 Jul 01 2015
Jazz misses Street 1Q forecasts May 07 2015
Jazz tops Street 4Q forecasts Feb 24 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK